Trial
NCT05341349
Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Emory University
Collaborators
National Cancer Institute (NCI); NovoCure Ltd.
Condition
Clinical Stage IV Cutaneous Melanoma AJCC v8
Intervention
Ipilimumab
Why stopped
Slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-23